Kaushik, Karishma S
Stolhandske, Jake
Shindell, Orrin
Smyth, Hugh D
Gordon, Vernita D
Article History
Received: 16 November 2015
Revised: 12 April 2016
Accepted: 14 April 2016
First Online: 25 May 2016
Competing interests
: H.D.S. holds stock in and received an honorarium from Respira Therapeutics. The terms of this arrangement have been reviewed and approved by the University of Texas at Austin in accordance with its policy on objectivity in research. The remaining authors declare no conflict of interest.